What You Should Know:
– DexCare, Inc., the market-leading platform provider for orchestrating patient demand and care access, today announced the appointment of Matthew Blosl as its new Chief Executive Officer and board member.
– Blosl takes the helm from Co-Founder Derek Streat, who successfully guided DexCare’s evolution from a spinout to a recognized category leader, facilitating care connections for over five million patients nationwide. Streat will transition to DexCare’s Board of Directors.
Blosl Bio/Background
Blosl brings over two decades of leadership experience to DexCare, with a strong background in fostering cultures of growth and operational excellence within technology-driven organizations. He is known for building high-performing teams and effectively scaling commercial operations, possessing a proven track record of executing growth strategies that deliver significant customer and enterprise value. Before joining DexCare, Blosl held a senior position at Experity, where he led commercial initiatives that significantly expanded the company’s market presence and were pivotal in establishing Experity’s leadership in the ambulatory electronic medical record market.
New Leadership to Drive Next Growth Phase
Matthew Blosl steps into the CEO role tasked with leading DexCare through its next stage of growth and scaling its impact across the healthcare ecosystem. His leadership will focus on accelerating platform innovation, notably incorporating AI-driven capabilities, and deepening market adoption among health systems. DexCare, backed by prominent institutional and strategic capital, already partners with leading U.S. health systems such as Kaiser Permanente, Piedmont, Providence, Texas Health Resources, and Community Health Network.
“DexCare’s platform is solving one of healthcare’s most urgent challenges—helping patients find and access the right care with the right provider at the right time,” said Blosl. “With an exceptional team, powerful technology, and deep health system partnerships, DexCare is poised for its next phase of growth. I am honored to lead the company as we scale our impact across the healthcare ecosystem.”
Co-Founders Transition to New Roles
As Blosl assumes the CEO position, DexCare’s co-founders take on new strategic roles. Derek Streat, credited with leading the company’s foundational growth and establishing its market leadership, will contribute his expertise and vision as a member of the Board of Directors. Additionally, acknowledging his crucial role in forging DexCare’s strategic partnerships and cultivating strong customer relationships, Co-Founder Sean O’Connor has been appointed President of the company.
